New

Next Generation Diabetes Therapy And Drug Delivery Market

2021

Next Generation Diabetes Therapy And Drug Delivery Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product Type (Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas); Indication (Type 1 Diabetes, Type 2 Diabetes); End-User (Diagnostics/Clinics, ICUs, Home Healthcare) and Geography

| Report Code: TIPRE00009660 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Market Insights

Next Generation Diabetes Therapy And Drug Delivery Market 2028 By Product Type, Indication, End-User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

The next generation diabetes therapy and the drug delivery devices are the advanced form of diabetic products that improve the quality of life of diabetic patients. Next generation efficient therapy for T1DM may help to improve the quality of life of diabetic patients who routinely employ insulin by the subcutaneous route.

MARKET DYNAMICS

Rise in incidence of diabetes, increase in healthcare expenditure & disposable income along with the benefits of next generation diabetes products over the regular products are the major factors propelling the market growth in the review period. However lack of awareness about the products may impede the market growth in the study period.

MARKET SCOPE

The "Global Next Generation Diabetes Therapy and Drug Delivery Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Next Generation Diabetes Therapy and Drug Delivery Market with detailed market segmentation by, product type, indication, end-user and geography. The Global Next Generation Diabetes Therapy and Drug Delivery Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Next Generation Diabetes Therapy and Drug Delivery Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Next Generation Diabetes Therapy and Drug Delivery Market is segmented on the basis of product type, indication, and end-user. Based on product type, it is classified into inhalable insulin, oral insulin, insulin patches, CGM systems, and artificial pancreas. Based on indication, it is divided into type 1 diabetes and type 2 diabetes. Based on end users, it is categorized into diagnostics/clinics, ICUs, and home healthcare.
?

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Next Generation Diabetes Therapy and Drug Delivery Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Next Generation Diabetes Therapy and Drug Delivery Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Next Generation Diabetes Therapy and Drug Delivery Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Next Generation Diabetes Therapy and Drug Delivery Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Next Generation Diabetes Therapy and Drug Delivery Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Next Generation Diabetes Therapy and Drug Delivery Market are anticipated to lucrative growth opportunities in the future with the rising demand for Next Generation Diabetes Therapy and Drug Delivery Market in the global market. Below mentioned is the list of few companies engaged in the Next Generation Diabetes Therapy and Drug Delivery Market.

The report also includes the profiles of key Next Generation Diabetes Therapy and Drug Delivery Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott Laboratories
- Medtronic, Inc.
- Sanofi
- Novo Nordisk
- MannKind Corporation
- Enteris BioPharma
- Dexcom, Inc.
- Senseonics Holding, Inc.
- Medtech
- Johnson & Johnson

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization `options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Next Generation Diabetes Therapy And Drug Delivery Market - By Product Type
1.3.2 Next Generation Diabetes Therapy And Drug Delivery Market - By Indication
1.3.3 Next Generation Diabetes Therapy And Drug Delivery Market - By End-User
1.3.4 Next Generation Diabetes Therapy And Drug Delivery Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY - GLOBAL MARKET OVERVIEW
6.2. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INHALABLE INSULIN
7.3.1. Overview
7.3.2. Inhalable Insulin Market Forecast and Analysis
7.4. ORAL INSULIN
7.4.1. Overview
7.4.2. Oral Insulin Market Forecast and Analysis
7.5. INSULIN PATCHES
7.5.1. Overview
7.5.2. Insulin Patches Market Forecast and Analysis
7.6. CGM SYSTEMS
7.6.1. Overview
7.6.2. CGM Systems Market Forecast and Analysis
7.7. ARTIFICIAL PANCREAS
7.7.1. Overview
7.7.2. Artificial Pancreas Market Forecast and Analysis
8. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. TYPE 1 DIABETES
8.3.1. Overview
8.3.2. Type 1 Diabetes Market Forecast and Analysis
8.4. TYPE 2 DIABETES
8.4.1. Overview
8.4.2. Type 2 Diabetes Market Forecast and Analysis
9. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTICS/CLINICS
9.3.1. Overview
9.3.2. Diagnostics/Clinics Market Forecast and Analysis
9.4. ICUS
9.4.1. Overview
9.4.2. ICUs Market Forecast and Analysis
9.5. HOME HEALTHCARE
9.5.1. Overview
9.5.2. Home Healthcare Market Forecast and Analysis
10. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.1.2 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.1.3 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.1.4 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.1.5 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.1.6 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.1.6.1 United States Next Generation Diabetes Therapy And Drug Delivery Market
10.1.6.1.1 United States Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.1.6.1.2 United States Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.1.6.1.3 United States Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.1.6.2 Canada Next Generation Diabetes Therapy And Drug Delivery Market
10.1.6.2.1 Canada Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.1.6.2.2 Canada Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.1.6.2.3 Canada Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.1.6.3 Mexico Next Generation Diabetes Therapy And Drug Delivery Market
10.1.6.3.1 Mexico Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.1.6.3.2 Mexico Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.1.6.3.3 Mexico Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2. EUROPE
10.2.1 Europe Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.2.2 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.2.3 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.2.4 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.2.5 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.2.6 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.1.1 Germany Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.1.2 Germany Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.1.3 Germany Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.2 France Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.2.1 France Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.2.2 France Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.2.3 France Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.3 Italy Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.3.1 Italy Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.3.2 Italy Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.3.3 Italy Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.4 Spain Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.4.1 Spain Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.4.2 Spain Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.4.3 Spain Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.5 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.5.1 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.5.2 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.5.3 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.3.2 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.3.3 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.1.1 Australia Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.1.2 Australia Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.1.3 Australia Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.2 China Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.2.1 China Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.2.2 China Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.2.3 China Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.3 India Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.3.1 India Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.3.2 India Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.3.3 India Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.4 Japan Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.4.1 Japan Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.4.2 Japan Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.4.3 Japan Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.5 South Korea Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.5.1 South Korea Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.5.2 South Korea Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.5.3 South Korea Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.4.2 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.4.3 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Next Generation Diabetes Therapy And Drug Delivery Market
10.4.6.1.1 South Africa Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.4.6.1.2 South Africa Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.4.6.1.3 South Africa Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.4.6.2 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market
10.4.6.2.1 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.4.6.2.2 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.4.6.2.3 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.4.6.3 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market
10.4.6.3.1 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.4.6.3.2 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.4.6.3.3 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.5.2 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.5.3 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.5.6 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Next Generation Diabetes Therapy And Drug Delivery Market
10.5.6.1.1 Brazil Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.5.6.1.2 Brazil Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.5.6.1.3 Brazil Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.5.6.2 Argentina Next Generation Diabetes Therapy And Drug Delivery Market
10.5.6.2.1 Argentina Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.5.6.2.2 Argentina Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.5.6.2.3 Argentina Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.5.6.3 Chile Next Generation Diabetes Therapy And Drug Delivery Market
10.5.6.3.1 Chile Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.5.6.3.2 Chile Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.5.6.3.3 Chile Next Generation Diabetes Therapy And Drug Delivery Market by End-User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MEDTRONIC, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVO NORDISK
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MANNKIND CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ENTERIS BIOPHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. DEXCOM, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SENSEONICS HOLDING, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MEDTECH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Medtronic, Inc.
3. Sanofi
4. Novo Nordisk
5. MannKind Corporation
6. Enteris BioPharma
7. Dexcom, Inc.
8. Senseonics Holding, Inc.
9. Medtech
10. Johnson and Johnson
TIPRE00009660
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.